Condition
Left Ventricular Assist Device
ClinicalTrials.gov condition label
Clinical trials
18 shownA Study of Metformin to Improve Cardiac Function After LVAD ImplantationNCT07666698 · 2026-07-01
RECRUITINGPreventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLureNCT06556485 · 2024-09-13
RECRUITINGPrognostic Value of BNP in MCS - a 25 Year Follow up StudyNCT04377854 · 2020-09-18
RECRUITINGREACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist DevicesNCT07611188 · 2026-05-01
NOT_YET_RECRUITINGPalliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD SupportNCT07445932 · 2026-03-01
NOT_YET_RECRUITINGHeart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world DataNCT07008729 · 2024-04-24
ACTIVE_NOT_RECRUITINGLVAD Index and Clinical Outcomes in Continuous-Flow LVAD PatientsNCT07633535 · 2022-10-01
COMPLETEDPreoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist DeviceNCT04205760 · 2022-01-02
UNKNOWNPROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist DevicesNCT04423562 · 2020-04-10
UNKNOWNSTandardized Ultra-conservative Or Physician-directed ICD Programming for Continuous Flow LVAD SupportNCT04264182 · 2020-02-03
TERMINATEDVeno-arterial Extracorporeal Membrane Oxygenation Prior to Left Ventricular Assist Device Implantation.NCT03583970 · 2018-07-05
UNKNOWNInfluence of Right Ventricular Function on Changes in Exercise Capacity After LVADNCT05916612 · 2018-07-01
WITHDRAWNCRD-102 for Right Heart Failure in Patients With Left Ventricular Assist DevicesNCT03217331 · 2018-03-06
COMPLETEDText Message Intervention to Improve Cardiac Rehab ParticipationNCT03346278 · 2017-11-07
TERMINATEDSubcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device SupportNCT03091998 · 2017-09-30
WITHDRAWNVentricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility TrialNCT03143569 · 2017-05-20
COMPLETEDExercise Tolerance in Patients With Implanted Left Ventricular Assist DeviceNCT05063006 · 2017-02-15
COMPLETEDPulse Wave Analysis in Advanced Heart FailureNCT01642927 · 2012-02-01
WITHDRAWNCommon interventions
2) Observation and collection and of blood sampleOTHER1Anti-factor Xa guided heparin managementDEVICE1aPTT guided heparin managementDEVICE1Cardiopulmonary exercise test with gradually increased pump speed depending on live echocardiographic imaging.OTHER1Cardiopulmonary exercise tests with maintained baseline optimal pump speed settings.OTHER1Catheter ablationPROCEDURE1CD-NPDRUG1Control (Standard treatment)OTHER1CRD-102DRUG1Heart monitoring tools (data revision)DEVICE1HeartMate 3 Left Ventricular Assist DeviceDEVICE1HeartWare Ventricular Assist DeviceDEVICE1ICD programmingOTHER1Left Ventricular Assist Device ImplantationDEVICE1Medical therapyDRUG1Metformin HydrochlorideDRUG1No interventionOTHER1Nutrition + exerciseCOMBINATION_PRODUCT1Observation. No intervention per se.OTHER1Palliative care interventionBEHAVIORAL1PlaceboDRUG1PlaceboOTHER1Remote Physical Conditioning Program (Telerehabilitation)OTHER1Text Messaging InterventionBEHAVIORAL1Usual care. No Remote Monitoring.OTHER1
Leading sponsors
Copenhagen University Hospital, Rigshospitalet2Puerta de Hierro University Hospital2Cardiora Pty. Ltd.1Central Hospital, Nancy, France1Gaziantep City Hospital1Heart and Diabetes Center North-Rhine Westfalia1Henry Ford Health System1Karol Wierzbicki1Mayo Clinic1Medstar Health Research Institute1RWTH Aachen University1The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1The Cleveland Clinic1University of Minnesota1University of Washington1
Trial status mix
COMPLETED4
RECRUITING3
UNKNOWN3
WITHDRAWN3
NOT_YET_RECRUITING2
TERMINATED2
ACTIVE_NOT_RECRUITING1
Phase mix
NA8
PHASE13
PHASE22
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.